Puma Biotechnology

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$52,436
$46,007
$59,077
$80,542
Gross Profit
40,135
35,451
45,156
51,445
EBITDA
10,765
8,240
17,700
26,586
EBIT
8,002
5,444
14,859
23,708
Net Income
5,855
2,974
19,305
20,317
Net Change In Cash
52,436
46,007
59,077
80,542
Free Cash Flow
14,062
3,551
15,591
11,018
Cash
54,662
63,030
69,219
67,263
Basic Shares
50,144
49,906
49,408
49,173

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$230,468
$235,637
$228,000
$253,200
Gross Profit
166,064
172,955
172,900
189,500
EBITDA
48,076
47,523
20,969
-5,397
EBIT
36,552
36,004
12,049
-15,995
Net Income
30,278
21,591
2
-29,100
Net Change In Cash
230,468
235,637
228,000
253,200
Cost of Revenue
3,500
-22,162
Free Cash Flow
38,862
14,369
-22,800
20,700
Cash
69,219
84,585
76,200
63,100
Basic Shares
49,100
47,550
44,929
40,638

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.15
2025-03-31
$0.10
2024-12-31
$0.43